InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Girgenti Steven. Officer active across 2 companies, notably bioAffinity Technologies, Inc.. Aggregated, 11 disclosures have been published. History available since 6 September 2022. The latest transaction was filed on 10 January 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
GIRGENTI STEVEN is a declarant linked to bioAffinity Technologies, Inc., where he is Executive Chairman, and to Vycor Medical INC, where he is Director. He has 11 filings in total, with all 11 included in the sampled set, and the recent filings are attribution filings spanning 2016-01-08 to 2025-01-14. The reported buy and sell volumes for the tracked recent filings are 0 EUR each.